These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 9591808)

  • 1. Vitiligo.
    Kovacs SO
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):647-66; quiz 667-8. PubMed ID: 9591808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitiligo: current medical and scientific understanding.
    Boissy RE; Nordlund JJ
    G Ital Dermatol Venereol; 2011 Feb; 146(1):69-75. PubMed ID: 21317859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genetics of generalized vitiligo.
    Spritz RA
    Curr Dir Autoimmun; 2008; 10():244-57. PubMed ID: 18460890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of the etiopathomechanism of vitiligo: a convergence theory.
    Le Poole IC; Das PK; van den Wijngaard RM; Bos JD; Westerhof W
    Exp Dermatol; 1993 Aug; 2(4):145-53. PubMed ID: 8162332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitiligo: where do we stand?
    Ortonne JP; Bose SK
    Pigment Cell Res; 1993 Mar; 6(2):61-72. PubMed ID: 8321867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokines: the yin and yang of vitiligo pathogenesis.
    Singh M; Kotnis A; Jadeja SD; Mondal A; Mansuri MS; Begum R
    Expert Rev Clin Immunol; 2019 Feb; 15(2):177-188. PubMed ID: 30462555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunopathogenesis of vitiligo.
    Sandoval-Cruz M; García-Carrasco M; Sánchez-Porras R; Mendoza-Pinto C; Jiménez-Hernández M; Munguía-Realpozo P; Ruiz-Argüelles A
    Autoimmun Rev; 2011 Oct; 10(12):762-5. PubMed ID: 21334464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanocyte destruction and repopulation in vitiligo.
    Norris DA; Horikawa T; Morelli JG
    Pigment Cell Res; 1994 Aug; 7(4):193-203. PubMed ID: 7855062
    [No Abstract]   [Full Text] [Related]  

  • 9. Dysregulation of melanocyte function by Th17-related cytokines: significance of Th17 cell infiltration in autoimmune vitiligo vulgaris.
    Kotobuki Y; Tanemura A; Yang L; Itoi S; Wataya-Kaneda M; Murota H; Fujimoto M; Serada S; Naka T; Katayama I
    Pigment Cell Melanoma Res; 2012 Mar; 25(2):219-30. PubMed ID: 22136309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune melanocyte destruction in vitiligo.
    van den Wijngaard R; Wankowicz-Kalinska A; Pals S; Weening J; Das P
    Lab Invest; 2001 Aug; 81(8):1061-7. PubMed ID: 11502857
    [No Abstract]   [Full Text] [Related]  

  • 11. Melanocyte destruction and repigmentation in vitiligo: a model for nerve cell damage and regrowth.
    Yu HS
    J Biomed Sci; 2002; 9(6 Pt 2):564-73. PubMed ID: 12432222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frontiers and controversies in the pathobiology of vitiligo: separating the wheat from the chaff.
    Boissy RE; Spritz RA
    Exp Dermatol; 2009 Jul; 18(7):583-5. PubMed ID: 19320739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients.
    van den Boorn JG; Konijnenberg D; Dellemijn TA; van der Veen JP; Bos JD; Melief CJ; Vyth-Dreese FA; Luiten RM
    J Invest Dermatol; 2009 Sep; 129(9):2220-32. PubMed ID: 19242513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitiligo. Pathogenesis and treatment.
    Njoo MD; Westerhof W
    Am J Clin Dermatol; 2001; 2(3):167-81. PubMed ID: 11705094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitiligo.
    Le Poole C; Boissy RE
    Semin Cutan Med Surg; 1997 Mar; 16(1):3-14. PubMed ID: 9125760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitiligo: Pathogenesis, clinical variants and treatment approaches.
    Iannella G; Greco A; Didona D; Didona B; Granata G; Manno A; Pasquariello B; Magliulo G
    Autoimmun Rev; 2016 Apr; 15(4):335-43. PubMed ID: 26724277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurogenic dysregulation, oxidative stress, autoimmunity, and melanocytorrhagy in vitiligo: can they be interconnected?
    Namazi MR
    Pigment Cell Res; 2007 Oct; 20(5):360-3. PubMed ID: 17850509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitiligo: pathogenetic hypotheses and targets for current therapies.
    Guerra L; Dellambra E; Brescia S; Raskovic D
    Curr Drug Metab; 2010 Jun; 11(5):451-67. PubMed ID: 20540698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitiligo.
    Nurs Times; 2005 May 31-Jun 6; 101(22):28. PubMed ID: 15960103
    [No Abstract]   [Full Text] [Related]  

  • 20. A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy?
    Gauthier Y; Cario Andre M; Taïeb A
    Pigment Cell Res; 2003 Aug; 16(4):322-32. PubMed ID: 12859615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.